Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

Background. In several prospective and retrospective studies, weekly paclitaxel showed promising activity in patients with angiosarcoma. Patients and Methods. Our study was originally designed as a prospective, phase II multicenter trial for patients younger than 75, with ECOG performance status 0–2...

Descripción completa

Detalles Bibliográficos
Autores principales: Apice, Gaetano, Pizzolorusso, Antonio, Di Maio, Massimo, Grignani, Giovanni, Gebbia, Vittorio, Buonadonna, Angela, De Chiara, Annarosaria, Fazioli, Flavio, De Palma, Giampaolo, Galizia, Danilo, Arcara, Carlo, Mozzillo, Nicola, Perrone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785388/
https://www.ncbi.nlm.nih.gov/pubmed/27019606
http://dx.doi.org/10.1155/2016/6862090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785388/
https://www.ncbi.nlm.nih.gov/pubmed/27019606
http://dx.doi.org/10.1155/2016/6862090

Ejemplares similares